Atlas Trials

Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial

Clinical trial NCT00629213 · COMPLETED

Trial details

NCT number
NCT00629213
Sponsor
GWT-TUD GmbH
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Metabolic Syndrome
Enrollment
1429

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.